High-Sensitivity C-Reactive Protein, Statin Therapy, and Risks of Atrial Fibrillation: An Exploratory Analysis of the JUPITER Trial

Study Questions:

Does reducing inflammation as indicated by high-sensitivity C-reactive protein (hs-CRP) with statins reduce the risk of atrial fibrillation (AF)?